COMPANY OVERVIEW

• Novartis is a pharmaceutical company founded in 1996 and is headquartered in Basel, Basel-Stadt.
• The company has 10,001+ employees who specialize in research, innovation, quality, sustainability, innovative medicines, generic medicines and biosimilars, a global leader in eye care, unique portfolio focuses & broad healthcare portfolio, cell & gene therapy, and data & digital.
• Novartis ranks among the world's top companies that are specializing in research and development. 
• The company's products reach close to one million people globally. 
• Novartis employs about 125,000 people from more than 140 nationalities. 
•  Basel, East Hanover, Dublin, Copenhagen, Prague, Panama City, and Bogota are the main locations of the company.
• On February 14, 2018, Novartis received a $6.5 million funding from Bill & Melinda Gates Foundation.
• In 2019 alone, Novartis has acquired IFM Tre and Xiidra in April and May, respectively.

NOVARTIS' FOCUS

• Novartis' key products are classified in various categories, which include active ingredients, disease area, and division.
• The company focuses on six disease areas which are cancer , cardiovascular, renal & metabolism , immunology & dermatology , ophthalmology , neuroscience , and respiratory .
• Novartis also focuses on platforms and technologies such as Artificial Intelligence and Cell and Gene therapy.